Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Radiopharmaceuticals Market Estimated to Reach US$8.5Bn by 2031: TMR Study

This image opens in the lightbox

News provided by

Transparency Market Research

24 Aug, 2022, 13:30 GMT

Share this article

Share toX

Share this article

Share toX

  • Radiopharmaceutical compounds have been deployed increasingly in different fields such as cardiology and neurology
  • Rising installation of PET-CT scanner devices helps North America emerge as leader in global radiopharmaceuticals market

WILMINGTON, Del., Aug. 24, 2022 /PRNewswire/ -- The global radiopharmaceuticals market is expected to grow at a CAGR of 7.3% during the forecast period between 2021 and 2031.Growing research and development undertakings is fueling the growth in radiopharmaceuticals market. Increasing application of radiolabeled peptides and monoclonal antibodies to detect and treat malignant tumors is fueling demand for radiopharmaceutical product, thereby stimulating global market growth.

Surge in demand for disease risk assessment services for oncology treatment as well as growing installation of PET-CT scanner devices in countries such as the U.S. and Canada helped North America in emerging as leader in overall market in 2020.

Asia Pacific is expected to witness significant growth in overall market during the forecast period between 2021 and 2031 owing to factors such as launch of new products as well as leading market players signing collaborative agreements with smaller players in countries such as India and China.

Get Exclusive PDF Sample Copy of Radiopharmaceuticals Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=213 

Radiopharmaceuticals Market –Key Findings of the Report

  • Patients worldwide are becoming increasingly aware of radiopharmaceutical compounds and their deployment in different medical areas such as oncology, neurology, and cardiology.
  • Nuclear medicine has contributed significantly to radiopharmaceuticals market in the last few decades.Increasing availability of technetium-99m to diagnose different diseases has contributed significantly to growth of nuclear medicine field and in turn, assisted in creating revenue-generating opportunities for well-established players in overall market.
  • Disease-targeted cancer therapy has witnessed increased demand to treat patients suffering from different types of cancer which has contributed to growth in radiopharmaceuticals market
  • 99m Tc isotope has witnessed increased demand for numerous diagnostic procedures such as neuroendocrine tumor and continuous. Furthermore, ongoing research and development activities to produce improved quality of products could further product demand in future.
  • Oncology indication segment is projected to make largest contribution to global radiopharmaceuticals market in the coming years. The key reason for maximum revenue contribution is growing radiopharmaceuticals demand for improved treatment access in clinical oncology which is expected to help generate revenue for leading players in radiopharmaceuticals market.
  • Technetium-99m compound segment is expected to emerge as largest revenue-contributor to global market because of increasing demand for use in imaging applications of different body parts such as pulmonary perfusion bones, lacrimal glands, and thyroid. Also, in comparison to other compounds, technetium-99m is cost-effective and can be manufactured easily, resulting in increased demand
  • The hospital segment is expected to make largest contribution to overall market in years to come. Surge in demand for installation of novel PET-CT machinery at hospitals in is expected to help create revenue-generating opportunities

Ask for References – https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=213 

Radiopharmaceuticals Market: Growth Drivers

  • Growing application of radiopharmaceutical compounds in neurology, cognitive neurosciences, and cardiology augments growth in overall market
  • Increased deployment as disease monitoring tool in patients suffering from cardiac sarcoidosis is propelling global market
  • Surge in number of diagnostic centers in developed countries such as the U.S. fuels growth in radiopharmaceutical market

Radiopharmaceuticals Market: Key Players

Global radiopharmaceuticals market has several prominent players, who have accounted for a large share in overall market for several years.

Presence of leading players has led to intense competition in radiopharmaceuticals market. It is anticipated that competition will further intensify with emergence of new players in the coming years.

Some of the key players operating in global radiopharmaceuticals market are:

  • Siemens Healthineers
  • GE Healthcare
  • Advanced Accelerator Applications
  • Jubilant Pharma Limited
  • Bayer AG
  • ITM Isotopen Technologize München AG
  • Telix Pharmaceuticals
  • Lantheus Holdings, Inc.
  • Eli Lilly and Company
  • Nihon Medi-Physics
  • Avanos Medical, Inc.

Make an Enquiry Before Buying – https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=213 

The global radiopharmaceuticals market is segmented as follows:

  • By Compound
  • Fluorine-18 Derivatives
    •  
      • Fluorine-18 Fludeoxyglucose (FDG)
      • Fluorine-18 Sodium Fluoride
      • Fluorine-18 Flucicovine
      • Fluorine-18 Florbetapir
      • Fluorine-18 Florbetaben
    • Others
    • Technetium-99
    • Lutetium (Lu) 177
  • Gallium-68
    •  
      • Dotatate
    • Dotatoc
    • Zirconium 89
    • 11C-choline
    • 14C-urea
    • Others

  Radiopharmaceuticals Market, by Indication

  • Oncology
  • Neurology
  • Neurodegenerative Diseases (AD, PD & Others)
  • Epilepsy
  • Cardiology
  • Others

  Radiopharmaceuticals Market, by System

  • PET
    • Standalone PET systems
    • Hybrid PET/CT
  • Hybrid PET/MRI
  • SPECT

  Radiopharmaceuticals Market, by End-user

  • Hospitals
  • Diagnostic Centers
  • Others

Radiopharmaceuticals Market, by Region

  North America:

  • U.S.
  • Canada

  Europe:

  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe

  Asia Pacific:

  • China
  • India
  • Japan
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Rest of the World

Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Research Reports by Transparency Market Research:

Non-invasive Ventilators Market: The global non-invasive ventilators market is anticipated to reach more than US$ 3.9 Bn by the end of 2031 with a CAGR of 5.9% from 2022 to 2031.

Medical Lifting Slings Market: The global medical lifting slings market is anticipated to reach more than US$ 1.34 Bn by the end of 2031 with a CAGR of 6.7% from 2022 to 2031.

Interspinous Spacers Market: The global interspinous spacers market is anticipated to reach more than US$ 127.33 Mn by 2031 with a CAGR of 6.09% from 2022 to 2031.

Collagen Dressings Market: The global collagen dressings market is anticipated to reach more than US$ 1.7 Bn by the end of 2031 with a CAGR of 5.5% from 2022 to 2031.

Mass Spectrometer Market: The global mass spectrometer market is anticipated to reach US$ 13.5 Bn by the end of 2031 with a CAGR of 8.2% from 2022 to 2031.

Protein Analyzers Market: The global protein analyzers market is anticipated to reach more than US$ 5.6 Bn by the end of 2031 with a CAGR of 8.5% from 2022 to 2031.

Prefilled Syringes Market: The global prefilled syringes market is anticipated to reach more than US$ 35.7 Bn by the end of 2031 with a CAGR of 10.1% from 2022 to 2031.

Digital Dose Inhalers Market: The global digital dose inhalers market is anticipated to reach more than US$ 7.22 Bn by 2031 with a CAGR of 12.5% from 2022 to 2031.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com

Logo: https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg 

Modal title

Also from this source

Ultra-high Purity Anhydrous Hydrogen Chloride (HCl) Gas Market to Reach USD 5.7 Billion by 2031, Expanding at a CAGR of 5.4% | TMR Report

Ultra-high Purity Anhydrous Hydrogen Chloride (HCl) Gas Market to Reach USD 5.7 Billion by 2031, Expanding at a CAGR of 5.4% | TMR Report

Over the last year, several companies have announced new semiconductor fabrication sites, especially in the U.S., India, and Europe. These...

Silicon Metal Market Size Projected to Expand to USD 10.7 Billion by 2031 Exhibiting 5.1% CAGR: Transparency Market Research, Inc.

Silicon Metal Market Size Projected to Expand to USD 10.7 Billion by 2031 Exhibiting 5.1% CAGR: Transparency Market Research, Inc.

The market was valued at US$ 6.9 billion in 2022. The Silicon Metal Market Growth is estimated to reach US$ 10.7 billion by the end of 2031,...

More Releases From This Source

Explore

Medical Pharmaceuticals

Medical Pharmaceuticals

Health Care & Hospitals

Health Care & Hospitals

Medical Equipment

Medical Equipment

Pharmaceuticals

Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.